A novel frameshift PKD1 mutation in a Chinese patient with autosomal dominant polycystic kidney disease and azoospermia: A case report

Meng,Jialin; Xu,Yuchen; Shen,Xufeng; Liang,Chaozhao

doi:10.3892/etm.2018.6946

A novel frameshift PKD1 mutation in a Chinese patient with autosomal dominant polycystic kidney disease and azoospermia: A case report

Authors:
- Jialin Meng
- Yuchen Xu
- Xufeng Shen
- Chaozhao Liang
View Affiliations

Affiliations: Department of Urology, The First Affiliated Hospital of Anhui Medical University and Institute of Urology, Anhui Medical University, Hefei, Anhui 230022, P.R. China
Published online on: November 9, 2018 https://doi.org/10.3892/etm.2018.6946
Pages: 507-511

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is primarily caused by mutations in polycystin 1, transient receptor potential channel interacting (PKD1) and PKD2, and characterized by numerous cysts in various organs, primarily the kidneys and liver. The present case report is on a 33‑year‑old Chinese male patient who suffered from abdominal pain and hypertension, and presented with long‑term infertility. Laboratory tests indicated that the patient had a normal renal function, while abdominal computed tomography demonstrated that the patient had enlarged kidneys with a volume of 1,127.21 cm3. In a semen analysis, no sperm was detected, while a subsequent testicular biopsy analysis demonstrated numerous mature sperms with progressive motility which suggests that the cysts of the epididymis and the dilated seminal vesicles may have obstructed the ejaculation of semen. Genetic testing identified that a novel missense mutation (c.9053delT) that was responsible for the disease. ADPKD has various disease severities, which depend on whether there is a PKD1 or PKD2 mutation and whether the mutation impairs the function of the polycystin protein. Therefore, genetic testing is important for the clinical diagnosis and prognosis of ADPKD patients, as well as prenatal diagnosis.

View Figures

View References

1	Dalgaard OZ: Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl. 328:1–255. 1957.PubMed/NCBI
2	Wilson PD: Polycystic kidney disease. N Engl J Med. 350:151–164. 2004. View Article : Google Scholar : PubMed/NCBI
3	Willey CJ, Blais JD, Hall AK, Krasa HB, Makin AJ and Czerwiec FS: Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol Dial Transplant. 32:1356–1363. 2017.PubMed/NCBI
4	Xue C, Zhou CC, Wu M and Mei CL: The clinical manifestation and management of autosomal dominant polycystic kidney disease in China. Kidney Dis (Basel). 2:111–119. 2016. View Article : Google Scholar : PubMed/NCBI
5	Pei Y and Watnick T: Diagnosis and screening of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis. 17:140–152. 2010. View Article : Google Scholar : PubMed/NCBI
6	Cornecle GE, Audrézet MP, Renaudineau E, Hourmant M, Charasse C, Michez E, Frouget T, Vigneau C, Dantal J, Siohan P, et al: PKD2-related autosomal dominant polycystic kidney disease: Prevalence, clinical presentation, mutation spectrum, and prognosis. Am J Kidney Dis. 70:476–485. 2017. View Article : Google Scholar : PubMed/NCBI
7	Reig B, Blumenfeld J, Donahue S and Prince MR: Seminal megavesicle in autosomal dominant polycystic kidney disease. Clin Imaging. 39:289–292. 2015. View Article : Google Scholar : PubMed/NCBI
8	Vikrant S and Parashar A: Autosomal dominant polycystic kidney disease: Study of clinical characteristics in an Indian population. Saudi J Kidney Dis Transpl. 28:115–124. 2017. View Article : Google Scholar : PubMed/NCBI
9	Yoshida H, Higashihara E, Maruyama K, Nutahara K, Nitatori T, Miyazaki I and Shiokawa Y: Relationship between intracranial aneurysms and the severity of autosomal dominant polycystic kidney disease. Acta Neurochir (Wien). 159:2325–2330. 2017. View Article : Google Scholar : PubMed/NCBI
10	Zhang W, Han Q, Liu Z and Zhou W, Cao Q and Zhou W: Whole exome sequencing reveals a stop-gain mutation of PKD2 in an autosomal dominant polycystic kidney disease family complicated with aortic dissection. BMC Med Genet. 19:192018. View Article : Google Scholar : PubMed/NCBI
11	Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, et al: Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 20:205–212. 2009. View Article : Google Scholar : PubMed/NCBI
12	Huskisson EC: Measurement of pain. Lancet. 2:1127–1131. 1974. View Article : Google Scholar : PubMed/NCBI
13	Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O'Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, et al: Analysis of protein-coding genetic variation in 60,706 humans. Nature. 536:285–291. 2016. View Article : Google Scholar : PubMed/NCBI
14	Gout AM, Martin NC, Brown AF and Ravine D: PKDB: Polycystic kidney disease mutation database-a gene variant database for autosomal dominant polycystic kidney disease. Hum Mutat. 28:654–659. 2007. View Article : Google Scholar : PubMed/NCBI
15	Moller M, Jöud M, Storry JR and Olsson ML: Erythrogene: A database for in-depth analysis of the extensive variation in 36 blood group systems in the 1,000 genomes project. Blood Adv. 1:240–249. 2016. View Article : Google Scholar : PubMed/NCBI
16	Porath B, Gainullin VG, Cornec-Le GE, Dillinger EK, Heyer CM, Hopp K, Edwards ME, Madsen CD, Mauritz SR, Banks CJ, et al: Mutations in GANAB, encoding the glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet. 98:1193–1207. 2016. View Article : Google Scholar : PubMed/NCBI
17	Codinasolà M, Rodríguezsantiago B, Homs A, Santoyo J, Rigau M, Aznar-Laín G, Del Campo M, Gener B, Gabau E, Botella MP, et al: Integrated analysis of whole-exome sequencing and transcriptome profiling in males with autism spectrum disorders. Mol Autism. 6:212015. View Article : Google Scholar : PubMed/NCBI
18	Oliver GR, Hart SN and Klee EW: Bioinformatics for clinical next generation sequencing. Clin Chem. 61:124–135. 2015. View Article : Google Scholar : PubMed/NCBI
19	Edrees BM, Athar M, Al-Allaf FA, Taher MM, Khan W, Bouazzaoui A, Al-Harbi N, Safar R, Al-Edressi H, Alansary K, et al: Next-generation sequencing for molecular diagnosis of autosomal recessive polycystic kidney disease. Gene. 591:214–226. 2016. View Article : Google Scholar : PubMed/NCBI
20	Ranjzad F, Aghdami N, Tara A, Mohseni M, Moghadasali R and Basiri A: Identification of three novel frameshift mutations in the PKD1 gene in iranian families with autosomal dominant polycystic kidney disease using efficient targeted next-generation sequencing. Kidney Blood Press Res. 43:471–478. 2018. View Article : Google Scholar : PubMed/NCBI
21	Steinberg KM, Schneider VA, Graves-Lindsay TA, Fulton RS, Agarwala R, Huddleston J, Shiryev SA, Morgulis A, Surti U, Warren WC, et al: Single haplotype assembly of the human genome from a hydatidiform mole. Genome Res. 24:2066–2076. 2014. View Article : Google Scholar : PubMed/NCBI
22	Chaisson MJ, Huddleston J, Dennis MY, Sudmant PH, Malig M, Hormozdiari F, Antonacci F, Surti U, Sandstrom R, Boitano M, et al: Resolving the complexity of the human genome using single-molecule sequencing. Nature. 517:608–611. 2015. View Article : Google Scholar : PubMed/NCBI
23	Bogdanova N, Markoff A, Gerke V, McCluskey M, Horst J and Dworniczak B: Homologues to the first gene for autosomal dominant polycystic kidney disease are pseudogenes. Genomics. 74:333–341. 2001. View Article : Google Scholar : PubMed/NCBI
24	Eisenberger T, Decker C, Hiersche M, Hamann RC, Decker E, Neuber S, Frank V, Bolz HJ, Fehrenbach H, Pape L, et al: An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease. PLoS One. 10:e01166802015. View Article : Google Scholar : PubMed/NCBI
25	Carrera P, Calzavara S, Magistroni R, den Dunnen JT, Rigo F, Stenirri S, Testa F, Messa P, Cerutti R, Scolari F, et al: Deciphering variability of PKD1 and PKD2 in an italian cohort of 643 patients with autosomal dominant polycystic kidney disease (ADPKD). Sci Rep. 6:308502016. View Article : Google Scholar : PubMed/NCBI
26	Borràs DM, Vossen RHAM, Liem M, Buermans HPJ, Dauwerse H, van Heusden D, Gansevoort RT, den Dunnen JT, Janssen B, Peters DJM, et al: Detecting PKD1 variants in polycystic kidney disease patients by single-molecule long-read sequencing. Hum Mutat. 38:870–879. 2017. View Article : Google Scholar : PubMed/NCBI
27	Xu D, Ma Y, Gu X, Bian R, Lu Y, Xing X and Mei C: Novel mutations in the PKD1 and PKD2 genes of Chinese patients with autosomal dominant polycystic kidney disease. Kidney Blood Press Res. 43:297–309. 2018. View Article : Google Scholar : PubMed/NCBI
28	Qian F, Germino FJ, Cai Y, Zhang X, Somlo S and Germino GG: PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet. 16:179–183. 1997. View Article : Google Scholar : PubMed/NCBI
29	Delmas P, Nomura H, Li X, Lakkis M, Luo Y, Segal Y, Fernández-Fernández JM, Harris P, Frischauf AM, Brown DA and Zhou J: Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J Biol Chem. 277:11276–11283. 2002. View Article : Google Scholar : PubMed/NCBI
30	Dere R, Wilson PD, Sandford RN and Walker CL: Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS One. 5:e92392010. View Article : Google Scholar : PubMed/NCBI
31	Kim H, Kang AY, Ko AR, Park HC, So I, Park JH, Cheong HI, Hwang YH and Ahn C: Calpain-mediated proteolysis of polycystin-1 C-terminus induces JAK2 and ERK signal alterations. Exp Cell Res. 320:62–68. 2014. View Article : Google Scholar : PubMed/NCBI
32	Cornec-Le Gall E, Audrezet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, et al: Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol. 24:1006–1013. 2013. View Article : Google Scholar : PubMed/NCBI
33	Kurashige M, Hanaoka K, Imamura M, Udagawa T, Kawaguchi Y, Hasegawa T, Hosoya T, Yokoo T and Maeda S: A comprehensive search for mutations in the PKD1 and PKD2 in Japanese subjects with autosomal dominant polycystic kidney disease. Clin Genet. 87:266–272. 2015. View Article : Google Scholar : PubMed/NCBI
34	Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, et al: Autosomal-dominant polycystic kidney disease (ADPKD): Executive summary from a kidney disease: Improving global outcomes (KDIGO) controversies conference. Kidney Int. 88:17–27. 2015. View Article : Google Scholar : PubMed/NCBI
35	Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF Jr, Wetzel LH, Kenney PJ, et al: Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: The consortium for radiologic imaging studies of polycystic kidney disease cohort. Clin J Am Soc Nephrol. 1:64–69. 2006. View Article : Google Scholar : PubMed/NCBI
36	Vlak MH, Algra A, Brandenburg R and Rinkel GJ: Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: A systematic review and meta-analysis. Lancet Neurol. 10:626–636. 2011. View Article : Google Scholar : PubMed/NCBI
37	Miskulin DC, Abebe KZ, Chapman AB, Perrone RD, Steinman TI, Torres VE, Bae KT, Braun W, Winklhofer FT, Hogan MC, et al: Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1–4: A cross-sectional study. Am J Kidney Dis. 63:214–226. 2014. View Article : Google Scholar : PubMed/NCBI
38	Perrone RD, Mouksassi MS, Romero K, Czerwiec FS, Chapman AB, Gitomer BY, Torres VE, Miskulin DC, Broadbent S and Marier JF: Total kidney volume is a prognostic biomarker of renal function decline and progression to end-stage renal disease in patients with autosomal dominant polycystic kidney disease. Kidney Int Rep. 2:442–450. 2017. View Article : Google Scholar : PubMed/NCBI
39	Yu ASL, Shen C, Landsittel DP, Harris PC, Torres VE, Mrug M, Bae KT, Grantham JJ, Rahbari-Oskoui FF, Flessner MF, et al: Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in autosomal dominant polycystic kidney disease. Kidney Int. 93:691–699. 2018. View Article : Google Scholar : PubMed/NCBI
40	Xue C, Zhou C and Mei C: Total kidney volume: The most valuable predictor of autosomal dominant polycystic kidney disease progression. Kidney Int. 93:540–542. 2018. View Article : Google Scholar : PubMed/NCBI
41	Torra R, Sarquella J, Calabia J, Martí J, Ars E, Fernández-Llama P and Ballarin J: Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 3:790–793. 2008. View Article : Google Scholar : PubMed/NCBI
42	Vora N, Perrone R and Bianchi DW: Reproductive issues for adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 51:307–318. 2008. View Article : Google Scholar : PubMed/NCBI
43	Kanagarajah P, Ayyathurai R and Lynne CM: Male infertility and adult polycystic kidney disease-revisited: Case report and current literature review. Andrologia. 44:838–841. 2012. View Article : Google Scholar : PubMed/NCBI
44	Grenha V, Pereira BJ, Retroz E, Coelhoa H, Godinhoa R, Temidoa P and Motaa A: Mechanisms of male infertility in autosomal dominant polycystic kidney disease. Acta Urológica Portuguesa. 31:41–44. 2014. View Article : Google Scholar
45	Shefi S, Levron J, Nadu A and Raviv G: Male infertility associated with adult dominant polycystic kidney disease: A case series. Arch Gynecol Obstet. 280:457–460. 2009. View Article : Google Scholar : PubMed/NCBI
46	Manno M, Marchesan E, Tomei F, Cicutto D, Maruzzi D, Maieron A and Turco A: Polycystic kidney disease and infertility: Case report and literature review. Arch Ital Urol Androl. 77:25–28. 2005.PubMed/NCBI
47	Hendry WF, Rickards D, Pryor JP and Baker LR: Seminal megavesicles with adult polycystic kidney disease. Hum Reprod. 13:1567–1569. 1998. View Article : Google Scholar : PubMed/NCBI
48	Li W, Ma Y, Yu S, Sun N, Wang L, Chen D, Yang G, Lu S, Li Y, Yang B and Mei C: The mutation-free embryo for in vitro fertilization selected by MALBAC-PGD resulted in a healthy live birth from a family carrying PKD 1 mutation. J Assist Reprod Genet. 34:1653–1658. 2017. View Article : Google Scholar : PubMed/NCBI
49	Murphy EL, Droher ML, Dimaio MS and Dahl NK: Preimplantation genetic diagnosis counseling in autosomal dominant polycystic kidney disease. Am J Kidney Dis. Mar 30–2018.(Epub ahead of print). View Article : Google Scholar